Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations.
Inoue D, Kitaura J, Togami K, Nishimura K, Enomoto Y, Uchida T, Kagiyama Y, Kawabata KC, Nakahara F, Izawa K, Oki T, Maehara A, Isobe M, Tsuchiya A, Harada Y, Harada H, Ochiya T, Aburatani H, Kimura H, Thol F, Heuser M, Levine RL, Abdel-Wahab O, Kitamura T. Inoue D, et al. Among authors: thol f. J Clin Invest. 2013 Nov;123(11):4627-40. doi: 10.1172/JCI70739. J Clin Invest. 2013. PMID: 24216483 Free PMC article.
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.
Thol F, Friesen I, Damm F, Yun H, Weissinger EM, Krauter J, Wagner K, Chaturvedi A, Sharma A, Wichmann M, Göhring G, Schumann C, Bug G, Ottmann O, Hofmann WK, Schlegelberger B, Heuser M, Ganser A. Thol F, et al. J Clin Oncol. 2011 Jun 20;29(18):2499-506. doi: 10.1200/JCO.2010.33.4938. Epub 2011 May 16. J Clin Oncol. 2011. PMID: 21576631
Rare occurrence of DNMT3A mutations in myelodysplastic syndromes.
Thol F, Winschel C, Lüdeking A, Yun H, Friesen I, Damm F, Wagner K, Krauter J, Heuser M, Ganser A. Thol F, et al. Haematologica. 2011 Dec;96(12):1870-3. doi: 10.3324/haematol.2011.045559. Epub 2011 Aug 31. Haematologica. 2011. PMID: 21880636 Free PMC article.
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.
Thol F, Kade S, Schlarmann C, Löffeld P, Morgan M, Krauter J, Wlodarski MW, Kölking B, Wichmann M, Görlich K, Göhring G, Bug G, Ottmann O, Niemeyer CM, Hofmann WK, Schlegelberger B, Ganser A, Heuser M. Thol F, et al. Blood. 2012 Apr 12;119(15):3578-84. doi: 10.1182/blood-2011-12-399337. Epub 2012 Mar 2. Blood. 2012. PMID: 22389253 Free article.
Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia.
Thol F, Scherr M, Kirchner A, Shahswar R, Battmer K, Kade S, Chaturvedi A, Koenecke C, Stadler M, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Bug G, Ottmann O, Hofmann WK, Kröger N, Fiedler W, Schlenk R, Döhner K, Döhner H, Krauter J, Eder M, Ganser A, Heuser M. Thol F, et al. Haematologica. 2015 Apr;100(4):e122-4. doi: 10.3324/haematol.2014.120345. Epub 2014 Dec 31. Haematologica. 2015. PMID: 25552704 Free PMC article. No abstract available.
[Myelodysplastic syndromes].
Thol F, Heuser M, Ganser A. Thol F, et al. Internist (Berl). 2015 Apr;56(4):364-73. doi: 10.1007/s00108-014-3598-3. Internist (Berl). 2015. PMID: 25700647 German.
Clonal Hematopoiesis of Indeterminate Potential.
Heuser M, Thol F, Ganser A. Heuser M, et al. Among authors: thol f. Dtsch Arztebl Int. 2016 May 6;113(18):317-22. doi: 10.3238/arztebl.2016.0317. Dtsch Arztebl Int. 2016. PMID: 27215596 Free PMC article. Review.
168 results